查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1464654

生物工艺验证市场，按测试类型、按工艺组件、按最终用户、按国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Bioprocess validation Market, By Test Type, By Process Component, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 260 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023 年生物製程验证市场规模为 4.2091 亿美元，2024 年至 2032 年复合年增长率为 9.83%。

生物製程验证市场-市场动态

外包生物製程验证需求的激增和生命科学研发支出的增加预计将推动市场成长。

许多製药和生物技术公司越来越多地委託其营运的各个方面，例如生物製程验证。随着生命科学领域研发活动的扩大，对生物製程验证相关服务的需求不断增加，以促进新生物製药产品的开发和生产。全球研发支出已飙升至近1.7兆美元，其中约10个国家贡献了80%的支出。根据联合国教科文组织统计研究所 (UIS) 的数据，作为永续发展目标 (SDG) 的一部分，各国承诺在 2030 年大幅增加公共和私人研发支出以及研究人员数量。此外，生物加工技术和监管合规要求的进步可能为市场带来成长机会。儘管如此，高昂的验证成本可能会阻碍市场成长。

生物製程验证市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 9.83% 左右的复合年增长率成长

根据测试类型细分，可萃取物和可浸出物测试预计将在 2023 年显示最大的市场份额

依製程元件细分，2023年过滤元件为主导类型

根据最终用户细分，製药和生物技术公司是 2023 年的领先类型

按地区划分，北美是 2023 年的主要收入来源

生物製程验证市场細項分析：

全球生物製程验证市场根据测试类型、製程组件、最终用户和地区进行细分。

根据测试类型，市场分为四组：可萃取物和可浸出物测试、生物製程残留物测试、病毒清除测试、过滤和发酵系统测试等。市场上的主导类别是可萃取物和可浸出物测试。此类测试在药品的开发和製造中发挥着至关重要的作用，特别是在生物製药生产中使用的包装材料、容器和加工设备方面。

根据製程组件，市场分为五类：过滤元件、介质容器和袋子、冷冻和解冻製程袋、混合系统、生物反应器、传输系统等。过滤元件是市场上的领先类别。它们在生物製药製造过程中发挥着至关重要的作用，特别是在下游加工中。

根据最终用户，市场分为三组：製药和生物技术公司、合约开发和製造组织以及其他。市场的主导力量是製药和生物技术公司。这些公司在推动生物製程验证服务的需求方面发挥着重要作用。鑑于他们参与生物製药产品的开发和生产，他们在製造过程中保持一致的品质并遵守监管标准至关重要。

生物製程验证市场-地理洞察

从地理上看，该市场横跨北美、拉丁美洲、欧洲、亚太地区、中东和非洲。这些区域根据对商业活动有贡献的国家进一步细分。由于对生物製药的需求不断增长，预计该市场将主要由北美（特别是美国）推动。美国拥有强大且完善的生物製药产业。生物製程验证在确保生物製药产品的品质、安全性和有效性方面发挥关键作用，导致对验证服务和产品的需求不断增加。根据《医药统计》，2021 年美国製药业收入为 5,500 亿美元，而美国人在药品上的支出为 5,769 亿美元。欧洲是第二大市场成长地区。

生物製程验证市场-竞争格局：

由于生物製药需求的不断增长、生物製程技术的进步以及严格的监管标准，生物製程验证市场正在经历大幅成长。该市场的製造商不断努力创新，创造用于验证生物过程的尖端技术和方法。透过保持创新的前沿，这些公司透过提供更有效率、更准确和更具成本效益的验证解决方案获得了竞争优势。此外，优先考虑客户满意度并建立牢固的消费者关係的公司通常会从重复业务和转移中受益，从而进一步增强其竞争地位。

最近的发展：

Eurofins BioPharma 产品测试哥伦比亚公司是全球最大的统一生物/製药GMP 产品测试设施网络的一部分，宣布与Plus Therapeutics, Inc.（“Plus Therapeutics”）达成合作协议，Plus Therapeutics 是一家临床阶段製药公司，开发罕见病的新型标靶疗法和困难的癌症。

2020 年 4 月 30 日，领先的科技公司 Merck 今天推出了其 BioContinuum 平台的下一个组件 Bio4C 软体套件，打造了一个首个生态系统，将製程控制、分析以及植物级自动化。

目录

第 1 章：生物製程验证市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按测试类型分類的生物工艺验证市场片段
    • 按工艺组件分類的生物工艺验证市场片段
    • 最终用户的生物工艺验证市场片段
    • 按国家/地区分類的生物工艺验证市场片段
    • 按地区分類的生物工艺验证市场片段
  • 竞争洞察

第 3 章：生物製程验证主要市场趋势

  • 生物製程验证市场驱动因素
    • 市场驱动因素的影响分析
  • 生物製程验证市场限制
    • 市场限制影响分析
  • 生物製程验证市场机会
  • 生物製程验证市场未来趋势

第 4 章：生物製程验证产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：生物製程验证市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：生物製程验证市场格局

  • 2023 年生物製程验证市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：生物製程验证市场 - 按测试类型

  • 概述
    • 按测试类型分類的细分市场份额分析
    • 可萃取物和可浸出物测试
    • 生物过程残留物测试
    • 病毒清除测试
    • 过滤和发酵系统测试
    • 其他的

第 8 章：生物製程验证市场 - 按製程组成部分

  • 概述
    • 按流程组件分類的细分市场占有率分析
    • 过滤元件
    • 媒体容器和袋子
    • 冷冻和解冻工艺袋
    • 混合系统
    • 生物反应器
    • 传输系统
    • 其他的

第 9 章：生物製程验证市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 製药与生物技术公司
    • 合约开发和製造组织
    • 其他

第 10 章：生物製程验证市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美生物製程验证主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按测试类型）
    • 北美市场规模和预测（按流程组件）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲生物製程验证主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按测试类型）
    • 欧洲市场规模和预测（按流程组件）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区生物製程验证主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 按测试类型分類的亚太市场规模和预测
    • 亚太地区市场规模与预测（按流程组成部分）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲生物製程验证主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模和预测（按测试类型）
    • 拉丁美洲市场规模与预测（按流程组成部分）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲生物製程验证主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按测试类型）
    • 中东和非洲市场规模和预测（按流程组成部分）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 生物製程验证产业

  • 竞争仪表板
  • 公司简介
    • Eurofins Scientific, Inc.
    • Sartorius AG
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • Lonza
    • Danaher Corporation
    • Charles River Laboratories
    • SGS SA
    • Toxikon Corporation
    • Cobetter Filtration Equipment Co., Ltd.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2456

REPORT HIGHLIGHT

Bioprocess validation Market size was valued at USD 420.91 Million in 2023, expanding at a CAGR of 9.83% from 2024 to 2032.

Bioprocess validation plays a vital role in guaranteeing the safety, quality, and effectiveness of bioproducts, including vaccines, antibodies, enzymes, and biosensors. Its purpose is to demonstrate that a bioprocess can consistently generate the desired bioproduct according to predetermined specifications and conditions. In the pharmaceutical industry, bioprocess validation is a mandatory regulatory requirement that ensures the uniformity and excellence of biopharmaceutical products throughout their entire lifespan.

Bioprocess validation Market- Market Dynamics

Surge in demand for outsourcing bioprocess validation and increase in life science R&D expenditure are expected to drive the market growth.

Numerous pharmaceutical and biotechnology companies are increasingly delegating various aspects of their operations, such as bioprocess validation. With the expansion of R&D activities in the life sciences sector, there is a rising demand for services related to bioprocess validation to facilitate the development and production of new biopharmaceutical products. Global expenditure on R&D has surged to nearly US$ 1.7 trillion, with approximately 10 countries contributing to 80% of the spending. As part of the Sustainable Development Goals (SDGs), nations have committed to significantly boosting public and private R&D expenditure, as well as the number of researchers, by 2030, as per the UNESCO Institute for Statistics (UIS). Additionally, advancements in bioprocessing technologies and regulatory compliance requirements may present growth opportunities for the market. Nonetheless, the high cost of validation could impede market growth.

Bioprocess validation Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.83% over the forecast period (2024-2032)

Based on Test Type segmentation, Extractables & Leachables Testing was predicted to show maximum market share in the year 2023

Based on Process Component segmentation, Filter Elements was the leading type in 2023

Based on End-User segmentation, Pharmaceutical & Biotechnology Companies was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Bioprocess validation Market- Segmentation Analysis:

The Global Bioprocess validation Market is segmented on the basis of Test Type, Process Component, End-User, and Region.

The market is categorized into four groups according to the Test Type: Extractables & Leachables Testing, Bioprocess Residuals Testing, Viral Clearance Testing, Filtration & Fermentation Systems Testing, and Others. The dominant category in the market is Extractables & Leachables Testing. This type of testing plays a crucial role in the development and manufacturing of pharmaceutical products, especially when it comes to packaging materials, containers, and processing equipment used in biopharmaceutical production.

The market is segmented into five categories according to Process Component: Filter Elements, Media containers and bags, Freezing And Thawing Process Bags, Mixing Systems, Bioreactors, Transfer Systems and Others. Filter Elements are the leading category in the market. They play a vital role in biopharmaceutical manufacturing processes, especially in downstream processing.

The market is segmented into three groups according to the end-users: Pharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organizations, and Other. The dominant force in the market is the Pharmaceutical & Biotechnology Companies. These companies play a significant role in driving the demand for bioprocess validation services. Given their involvement in the development and production of biopharmaceutical products, it is crucial for them to maintain consistent quality and adhere to regulatory standards in their manufacturing processes.

Bioprocess validation Market- Geographical Insights

Geographically, this market spans across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented by countries contributing to business activities. The market is anticipated to be primarily driven by North America, particularly the United States, owing to the rising demand for Biopharmaceuticals. The United States boasts a strong and well-established biopharmaceutical industry. Validation of bioprocesses plays a critical role in ensuring the quality, safety, and effectiveness of biopharmaceutical products, leading to an increased demand for validation services and products. As per Pharmaceutical Statistics, the U.S. pharmaceutical industry recorded a revenue of $550 billion in 2021, while Americans spent USD 576.9 billion on medications. Europe stands as the second-largest region for market growth.

Bioprocess validation Market- Competitive Landscape:

The bioprocess validation market is experiencing substantial growth as a result of the rising need for biopharmaceuticals, advancements in bioprocess technology, and strict regulatory standards. Manufactures in this market are constantly striving to innovate and create cutting-edge technologies and methodologies for validating bioprocesses. By staying at the forefront of innovation, these companies gain a competitive advantage by providing validation solutions that are more efficient, accurate, and cost-effective. Additionally, companies that prioritize customer satisfaction and establish strong consumer relationships often benefit from repeat business and transfers, further enhancing their competitive position.

Recent Developments:

Eurofins BioPharma Product Testing Columbia part of the biggest network of harmonized bio/pharmaceutical GMP product testing facilities globally, announced a collaboration agreement with Plus Therapeutics, Inc. ("Plus Therapeutics"), a clinical stage pharmaceutical company developing novel, targeted therapies for rare and difficult cancers.

April 30, 2020, Merck, a leading science and technology company, today unveiled the next component of its BioContinuum Platform, the Bio4C Software Suite, generating a first-of-its-kind ecosystem that syndicates process control, analytics as well as plant-level automation.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOPROCESS VALIDATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Eurofins Scientific, Inc.

Sartorius AG

Merck KGaA

Thermo Fisher Scientific Inc.

Lonza

Danaher Corporation

Charles River Laboratories

SGS S.A.

Toxikon Corporation

Cobetter Filtration Equipment Co., Ltd.

Others

GLOBAL BIOPROCESS VALIDATION MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Extractables & Leachables Testing
  • Bioprocess Residuals Testing
  • Viral Clearance Testing
  • Filtration & Fermentation Systems Testing
  • Others

GLOBAL BIOPROCESS VALIDATION MARKET, BY PROCESS COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Filter Elements
  • Media containers and bags
  • Freezing And Thawing Process Bags
  • Mixing Systems
  • Bioreactors
  • Transfer Systems
  • Others

GLOBAL BIOPROCESS VALIDATION MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical & Biotechnology Companies
  • Contract Development & Manufacturing Organizations
  • Other

GLOBAL BIOPROCESS VALIDATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Bioprocess Validation Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Bioprocess Validation Market Snippet by Test Type
    • 2.1.2.Bioprocess Validation Market Snippet by Process Component
    • 2.1.3.Bioprocess Validation Market Snippet by End-User
    • 2.1.4.Bioprocess Validation Market Snippet by Country
    • 2.1.5.Bioprocess Validation Market Snippet by Region
  • 2.2.Competitive Insights

3.Bioprocess Validation Key Market Trends

  • 3.1.Bioprocess Validation Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Bioprocess Validation Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Bioprocess Validation Market Opportunities
  • 3.4.Bioprocess Validation Market Future Trends

4.Bioprocess Validation Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Bioprocess Validation Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Bioprocess Validation Market Landscape

  • 6.1.Bioprocess Validation Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Bioprocess Validation Market - By Test Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Test Type, 2023 & 2032 (%)
    • 7.1.2.Extractables & Leachables Testing
    • 7.1.3.Bioprocess Residuals Testing
    • 7.1.4.Viral Clearance Testing
    • 7.1.5.Filtration & Fermentation Systems Testing
    • 7.1.6.Others

8.Bioprocess Validation Market - By Process Component

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Process Component, 2023 & 2032 (%)
    • 8.1.2.Filter Elements
    • 8.1.3.Media containers and bags
    • 8.1.4.Freezing And Thawing Process Bags
    • 8.1.5.Mixing Systems
    • 8.1.6.Bioreactors
    • 8.1.7.Transfer Systems
    • 8.1.8.Others

9.Bioprocess Validation Market - By End-User

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2.Pharmaceutical & Biotechnology Companies
    • 9.1.3.Contract Development & Manufacturing Organizations
    • 9.1.4.Other

10.Bioprocess Validation Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Bioprocess Validation Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Bioprocess Validation Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Bioprocess Validation Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Bioprocess Validation Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Bioprocess Validation Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Bioprocess Validation Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Eurofins Scientific, Inc.
    • 11.2.2.Sartorius AG
    • 11.2.3.Merck KGaA
    • 11.2.4.Thermo Fisher Scientific Inc.
    • 11.2.5.Lonza
    • 11.2.6.Danaher Corporation
    • 11.2.7.Charles River Laboratories
    • 11.2.8.SGS S.A.
    • 11.2.9.Toxikon Corporation
    • 11.2.10.Cobetter Filtration Equipment Co., Ltd.
    • 11.2.11.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Bioprocess Validation Market: Test Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Test Type
  • TABLE Global Bioprocess Validation Market, by Test Type 2019-2032 (USD Million)
  • TABLE Bioprocess Validation Market: Process Component Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Process Component
  • TABLE Global Bioprocess Validation Market, by Process Component 2019-2032 (USD Million)
  • TABLE Bioprocess Validation Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Bioprocess Validation Market, by End-User 2019-2032 (USD Million)
  • TABLE Bioprocess Validation Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Bioprocess Validation Market, by Region 2019-2032 (USD Million)
  • TABLE North America Bioprocess Validation Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Bioprocess Validation Market, by Test Type, 2019-2032 (USD Million)
  • TABLE North America Bioprocess Validation Market, by Process Component, 2019-2032 (USD Million)
  • TABLE North America Bioprocess Validation Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe Bioprocess Validation Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Bioprocess Validation Market, by Test Type, 2019-2032 (USD Million)
  • TABLE Europe Bioprocess Validation Market, by Process Component, 2019-2032 (USD Million)
  • TABLE Europe Bioprocess Validation Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Bioprocess Validation Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Bioprocess Validation Market, by Test Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Bioprocess Validation Market, by Process Component, 2019-2032 (USD Million)
  • TABLE Asia Pacific Bioprocess Validation Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America Bioprocess Validation Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Bioprocess Validation Market, by Test Type, 2019-2032 (USD Million)
  • TABLE Latin America Bioprocess Validation Market, by Process Component, 2019-2032 (USD Million)
  • TABLE Latin America Bioprocess Validation Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Bioprocess Validation Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Bioprocess Validation Market, by Test Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Bioprocess Validation Market, by Process Component, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Bioprocess Validation Market, by End-User, 2019-2032 (USD Million)